Результати пошуку - Guido Giordano

  • Показ 1 - 17 результатів із 17
Уточнити результати
  1. 1
    Immune Resistance and EGFR Antagonists in Colorectal Cancer

    Immune Resistance and EGFR Antagonists in Colorectal Cancer за авторством Guido Giordano, Andrea Remo, Almudena Porrás, Massimo Pancione

    Опубліковано 2019
    Отримати повний текст Отримати повний текст
    Revisão
    Додати у Вибране
    Збережено в:
  2. 2
    Cancer-Associated Immune Resistance and Evasion of Immune Surveillance in Colorectal Cancer

    Cancer-Associated Immune Resistance and Evasion of Immune Surveillance in Colorectal Cancer за авторством Pietro Parcesepe, Guido Giordano, Carmelo Laudanna, Antonio Febbraro, Massimo Pancione

    Опубліковано 2016
    Отримати повний текст Отримати повний текст
    Revisão
    Додати у Вибране
    Збережено в:
  3. 3
    Staphylococcus lugdunensis, a serious pathogen in periprosthetic joint infections: comparison to Staphylococcus aureus and Staphylococcus epidermidis

    Staphylococcus lugdunensis, a serious pathogen in periprosthetic joint infections: comparison to Staphylococcus aureus and Staphylococcus epidermidis за авторством Julie Lourtet-Hascoët, A. Bicart-See, M P Félicé, Guido Giordano, É. Bonnet

    Опубліковано 2016
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  4. 4
    Real-world comparative effectiveness of nab-paclitaxel plus gemcitabine <i>versus</i> FOLFIRINOX in advanced pancreatic cancer: a systematic review

    Real-world comparative effectiveness of nab-paclitaxel plus gemcitabine <i>versus</i> FOLFIRINOX in advanced pancreatic cancer: a systematic review за авторством E. Gabriela Chiorean, Winson Y. Cheung, Guido Giordano, George Kim, Salah‐Eddin Al‐Batran

    Опубліковано 2019
    Отримати повний текст Отримати повний текст
    Revisão
    Додати у Вибране
    Збережено в:
  5. 5
    Species and antimicrobial susceptibility testing of coagulase-negative staphylococci in periprosthetic joint infections

    Species and antimicrobial susceptibility testing of coagulase-negative staphylococci in periprosthetic joint infections за авторством Julie Lourtet-Hascoët, M P Félicé, A. Bicart-See, A Bouige, Guido Giordano, É. Bonnet

    Опубліковано 2018
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  6. 6
    Immune Escape Mechanisms in Colorectal Cancer Pathogenesis and Liver Metastasis

    Immune Escape Mechanisms in Colorectal Cancer Pathogenesis and Liver Metastasis за авторством Massimo Pancione, Guido Giordano, Andrea Remo, Antonio Febbraro, Lina Sabatino, Erminia Manfrin, Michele Ceccarelli, Vittorio Colantuoni

    Опубліковано 2014
    Отримати повний текст Отримати повний текст
    Revisão
    Додати у Вибране
    Збережено в:
  7. 7
    Nano albumin bound-paclitaxel in pancreatic cancer: Current evidences and future directions

    Nano albumin bound-paclitaxel in pancreatic cancer: Current evidences and future directions за авторством Guido Giordano, Massimo Pancione, Nunzio Olivieri, Pietro Parcesepe, Marianna Velocci, Tania Di Raimo, Luigi Coppola, Giuseppe Toffoli, Mario D’Andrea

    Опубліковано 2017
    Отримати повний текст
    Revisão
    Додати у Вибране
    Збережено в:
  8. 8
    Targeting Angiogenesis and Tumor Microenvironment in Metastatic Colorectal Cancer: Role of Aflibercept

    Targeting Angiogenesis and Tumor Microenvironment in Metastatic Colorectal Cancer: Role of Aflibercept за авторством Guido Giordano, Antonio Febbraro, Michele Venditti, Serena Campidoglio, Nunzio Olivieri, Katia Raieta, Pietro Parcesepe, Giusy Carmen Imbriani, Andrea Remo, Massimo Pancione

    Опубліковано 2014
    Отримати повний текст Отримати повний текст
    Revisão
    Додати у Вибране
    Збережено в:
  9. 9
    Morphology and Molecular Features of Rare Colorectal Carcinoma Histotypes

    Morphology and Molecular Features of Rare Colorectal Carcinoma Histotypes за авторством Andrea Remo, Matteo Fassan, Alessandro Vanoli, Luca Reggiani Bonetti, Valeria Barresi, Fabiana Tatangelo, Roberta Gafà, Guido Giordano, Massimo Pancione, Federica Grillo, Luca Mastracci

    Опубліковано 2019
    Отримати повний текст Отримати повний текст
    Revisão
    Додати у Вибране
    Збережено в:
  10. 10
    Recurrent Glioblastoma Treatment: State of the Art and Future Perspectives in the Precision Medicine Era

    Recurrent Glioblastoma Treatment: State of the Art and Future Perspectives in the Precision Medicine Era за авторством Augusto Leone, Antonio Colamaria, Nicola Pio Fochi, Matteo Antonio Sacco, Matteo Landriscina, Giovanni Parbonetti, Matteo de Notaris, Giulia Coppola, Elena De Santis, Guido Giordano, Francesco Carbone

    Опубліковано 2022
    Отримати повний текст Отримати повний текст
    Revisão
    Додати у Вибране
    Збережено в:
  11. 11
    NAB-paclitaxel and gemcitabine in metastatic pancreatic ductal adenocarcinoma (PDAC): from clinical trials to clinical practice

    NAB-paclitaxel and gemcitabine in metastatic pancreatic ductal adenocarcinoma (PDAC): from clinical trials to clinical practice за авторством Ferdinando De Vita, Jole Ventriglia, Antonio Febbraro, Maria Maddalena Laterza, Alessio Fabozzi, B. Savastano, Angelica Petrillo, Anna Diana, Guido Giordano, Teresa Troiani, Giovanni Conzo, Gennaro Galizia, Fortunato Ciardiello, Michele Orditura

    Опубліковано 2016
    Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  12. 12
    Cancer-related CD15/FUT4 overexpression decreases benefit to agents targeting EGFR or VEGF acting as a novel RAF-MEK-ERK kinase downstream regulator in metastatic colorectal cancer

    Cancer-related CD15/FUT4 overexpression decreases benefit to agents targeting EGFR or VEGF acting as a novel RAF-MEK-ERK kinase downstream regulator in metastatic colorectal cancer за авторством Guido Giordano, Antonio Febbraro, Eugenio Tomaselli, Maria Lucia Sarnicola, Pietro Parcesepe, Domenico Parente, Nicola Forte, Alessio Fabozzi, Andrea Remo, Andrea Bonetti, Erminia Manfrin, Somayehsadat Ghasemi, Michele Ceccarelli, Luigi Cerulo, Flavia Bazzoni, Massimo Pancione

    Опубліковано 2015
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  13. 13
    JAK/Stat5-mediated subtype-specific lymphocyte antigen 6 complex, locus G6D (LY6G6D) expression drives mismatch repair proficient colorectal cancer

    JAK/Stat5-mediated subtype-specific lymphocyte antigen 6 complex, locus G6D (LY6G6D) expression drives mismatch repair proficient colorectal cancer за авторством Guido Giordano, Pietro Parcesepe, Mario D’Andrea, Luigi Coppola, Tania Di Raimo, Andrea Remo, Erminia Manfrin, Claudia Fiorini, Aldo Scarpa, Carla Azzurra Amoreo, Fabiana Conciatori, Michèle Milella, Francesca Pia Caruso, Luigi Cerulo, Almudena Porrás, Massimo Pancione

    Опубліковано 2019
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  14. 14
    The role of nanoliposomal irinotecan plus fluorouracil/leucovorin in the continuum of care of patients with metastatic pancreatic ductal adenocarcinoma

    The role of nanoliposomal irinotecan plus fluorouracil/leucovorin in the continuum of care of patients with metastatic pancreatic ductal adenocarcinoma за авторством Letizia Procaccio, Valeria Merz, Morena Fasano, Vanja Vaccaro, Elisa Giommoni, Andrea Pretta, Silvia Noventa, Maria Antonietta Satolli, Guido Giordano, Clizia Zichi, Carmine Pinto, Camilla Zecchetto, Giulia Barsotti, Ferdinando De Vita, Michèle Milella, Lorenzo Antonuzzo, Mario Scartozzi, Alberto Zaniboni, Rosella Spadi, Simona Casalino, Francesca Bergamo, Chiara De Toni, Davide Melisi, Sara Lonardi

    Опубліковано 2023
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  15. 15
    What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 1: Focus on Immunohistochemical Results with Discussion of Pre-Analytical and Interpretation Variables

    What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 1: Focus on Immunohistochemical Results with Discussion of Pre-Analytical an... за авторством Andrea Palicelli, Martina Bonacini, Stefania Croci, Cristina Magi‐Galluzzi, Sofía Cañete‐Portillo, Alcides Chaux, Alessandra Bisagni, Eleonora Zanetti, Dario de Biase, Beatrice Melli, Francesca Sanguedolce, Moira Ragazzi, Maria Paola Bonasoni, Alessandra Soriano, Stefano Ascani, Maurizio Zizzo, Carolina Castro Ruiz, Antonio De Leo, Guido Giordano, Matteo Landriscina, Giuseppe Carrieri, Luigi Cormio, Daniel M. Berney, Daniel Abensur Athanazio, Jatin Gandhi, Alberto Cavazza, Giacomo Santandrea, Alessandro Tafuni, Magda Zanelli

    Опубліковано 2021
    Отримати повний текст Отримати повний текст
    Revisão
    Додати у Вибране
    Збережено в:
  16. 16
    Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: An early exploratory analysis of real‐world data

    Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: An early exploratory analysis of real‐world data за авторством Margherita Rimini, Lorenzo Fornaro, Sara Lonardi, Monica Niger, Daniele Lavacchi, Tiziana Pressiani, Jessica Lucchetti, Guido Giordano, Andrea Pretta, Emiliano Tamburini, Chiara Pirrone, Ilario Giovanni Rapposelli, Anna Diana, Erika Martinelli, Ingrid Garajová, Francesca Simionato, Marta Schirripa, Vincenzo Formica, Caterina Vivaldi, Enrico Caliman, Mario Domenico Rizzato, Valentina Zanuso, Federico Nichetti, Lorenzo Angotti, Matteo Landriscina, Mario Scartozzi, Matteo Ramundo, Alessandro Pastorino, Bruno Daniele, Noemi Cornara, Mara Persano, Eleonora Gusmaroli, Riccardo Cerantola, Francesca Salani, Francesca Ratti, Luca Aldrighetti, Stefano Cascinu, Lorenza Rimassa, Lorenzo Antonuzzo, Andrea Casadei‐Gardini

    Опубліковано 2023
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  17. 17
    Cetuximab continuation after first progression in metastatic colorectal cancer (CAPRI-GOIM): a randomized phase II trial of FOLFOX plus cetuximab versus FOLFOX

    Cetuximab continuation after first progression in metastatic colorectal cancer (CAPRI-GOIM): a randomized phase II trial of FOLFOX plus cetuximab versus FOLFOX за авторством Fortunato Ciardiello, Nicola Normanno, Erika Martinelli, Teresa Troiani, Salvatore Pisconti, Claudia Cardone, Annarita Nappi, Roberto Bordonaro, Anna Maria Rachiglio, Matilde Lambiase, T. Latiano, G. Modoni, Stefano Cordio, Francesco Giuliani, M. Biglietto, Vincenzo Montesarchio, Carlo Barone, Giuseppe Tonini, Saverio Cinieri, Antonio Febbraro, Daniele Rizzi, Ferdinando De Vita, Michele Orditura, Giuseppe Colucci, Evaristo Maiello, Vincenzo Rosario Iaffaioli, Guglielmo Nasti, Gerardo Botti, Fabiana Tatangelo, Nicoletta Chicchinelli, Michele Montrone, Annamaria Sebastio, Tiziana Guarino, Gianni Simone, Paolo Graziano, Cinzia Chiarazzo, G. Di Maggio, Laura Longhitano, M Manusia, Giacomo Cartenì, Oscar Nappi, Pietro Micheli, Luigi Leo, Sabrina Rossi, Alessandra Cassano, Eugenio Tommaselli, Guido Giordano, F. Sponziello, Antonella Marino, Antonio Rinaldi, S. Romito, Andrea Onetti Muda, Vito Lorusso, Silvana Leo, Sandro Barni, Giuseppe Grimaldi, Michele Aieta

    Опубліковано 2016
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:

Інструменти для пошуку: